Nutranomics Number Of Employees vs. Market Capitalization
| NNRX Stock | USD 0.0001 0.00 0.00% |
For Nutranomics profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Nutranomics to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Nutranomics utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Nutranomics's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Nutranomics over time as well as its relative position and ranking within its peers.
Nutranomics |
Nutranomics Market Capitalization vs. Number Of Employees Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Nutranomics's current stock value. Our valuation model uses many indicators to compare Nutranomics value to that of its competitors to determine the firm's financial worth. Nutranomics is rated below average in number of employees category among its peers. It also is rated below average in market capitalization category among its peers creating about 29,033 of Market Capitalization per Number Of Employees. Comparative valuation analysis is a catch-all model that can be used if you cannot value Nutranomics by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Nutranomics' Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Nutranomics Number Of Employees vs. Competition
Nutranomics is rated below average in number of employees category among its peers. The total workforce of Drug Manufacturers—Specialty & Generic industry is now estimated at about 206. Nutranomics adds roughly 1.0 in number of employees claiming only tiny portion of equities under Drug Manufacturers—Specialty & Generic industry.
Nutranomics Market Capitalization vs. Number Of Employees
Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.
Nutranomics |
| = | 1 |
Employee typically refers to an individual working under a contract of employment, whether oral or written, express or implied, and has recognized his or her rights and duties. Most officers of corporations are included as employees and contractors are generally excluded.
Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Nutranomics |
| = | 29.03 K |
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.
Nutranomics Market Capitalization vs Competition
Nutranomics is rated below average in market capitalization category among its peers. Market capitalization of Drug Manufacturers—Specialty & Generic industry is now estimated at about 32.79 Million. Nutranomics adds roughly 29,033 in market capitalization claiming only tiny portion of equities under Drug Manufacturers—Specialty & Generic industry.
Nutranomics Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Nutranomics, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Nutranomics will eventually generate negative long term returns. The profitability progress is the general direction of Nutranomics' change in net profit over the period of time. It can combine multiple indicators of Nutranomics, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Nutranomics, Inc. engages in the research, development, and sale of nutritional food products. The company was founded in 1995 and is headquartered in Salt Lake City, Utah. Nutranomics operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 1 people.
Nutranomics Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Nutranomics. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Nutranomics position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Nutranomics' important profitability drivers and their relationship over time.
Use Nutranomics in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Nutranomics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nutranomics will appreciate offsetting losses from the drop in the long position's value.Nutranomics Pair Trading
Nutranomics Pair Trading Analysis
The ability to find closely correlated positions to Nutranomics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Nutranomics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Nutranomics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Nutranomics to buy it.
The correlation of Nutranomics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Nutranomics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Nutranomics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Nutranomics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Nutranomics position
In addition to having Nutranomics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Large Growth Funds Thematic Idea Now
Large Growth Funds
Funds or Etfs that invest in stocks of large-sized companies with above-average risk and growth rate. The Large Growth Funds theme has 41 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Large Growth Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Nutranomics Pink Sheet Analysis
When running Nutranomics' price analysis, check to measure Nutranomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nutranomics is operating at the current time. Most of Nutranomics' value examination focuses on studying past and present price action to predict the probability of Nutranomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nutranomics' price. Additionally, you may evaluate how the addition of Nutranomics to your portfolios can decrease your overall portfolio volatility.